COVID-19 vaccination BNT162b2 temporarily impairs semen concentration and total motile count among semen donors

Journal: Andrology
Lead Author: Gat, et al.
Original date of publication: 06/01/2022
Link: https://www.researchgate.net/publication/361392999_Covid-19_vaccination_BNT162b2_temporarily_impairs_semen_concentration_and_total_motile_count_among_semen_donors

Summary Context

This study revealed the damage to men’s motile sperm count after the Pfizer 2-shot series among sperm donors.

Comments

This article is copyrighted by Health Freedom Defense Fund, Inc.
Visit our Re-post guidelines

This study examined 37 sperm donors who gave 216 samples after 2 doses of Pfizer injection. Witnesses a 35% reduction in total motile sperm count in the short term.

Abstract or Results, Key Passages

“Systemic immune response after BNT162b2 vaccine is a reasonable cause for transient semen concentration and TMC decline.”

Keywords: adverse events andrology clinical trials covid vaccination fertility Moderna mRNA Pfizer semen count

Full Author List: Itai Gat, Alon Kedem, Michal DviriShow, Micha Baum

COVID-19 vaccination BNT162b2 temporarily impairs semen concentration and total motile count among semen donors

Summary Context

Comments

Abstract or Results, Key Passages

Previous PostIntracellular reverse transcription of Pfizer human liver cell line

Next PostSerious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults